CN Stock MarketDetailed Quotes

000623 Jilin Aodong Pharmaceutical Group

Watchlist
  • 14.99
  • +0.03+0.20%
Not Open May 13 15:00 CST
17.93BMarket Cap16.03P/E (TTM)

Jilin Aodong Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
46.35%1.63B
19.59%1.72B
23.31%1.86B
50.98%1.94B
-32.33%1.12B
-17.46%1.44B
-8.68%1.51B
-13.30%1.28B
-26.09%1.65B
-30.40%1.74B
Transactional financial assets
-15.42%1.45B
1.11%1.66B
16.89%1.76B
-5.89%1.74B
-10.46%1.71B
-25.08%1.64B
-41.01%1.51B
-16.81%1.85B
48.88%1.91B
68.35%2.19B
Notes receivable and accounts receivable
35.87%1.32B
30.07%1.01B
22.24%1.07B
12.01%932.33M
20.33%971.68M
26.36%776.64M
-3.14%878.02M
-0.09%832.38M
-23.89%807.48M
-35.38%614.6M
-Notes receivable
-99.91%101.15K
----
----
--4.55M
--111.78M
--88.13M
----
----
----
----
-Accounts receivable
53.51%1.32B
46.72%1.01B
22.24%1.07B
11.46%927.78M
6.49%859.9M
12.02%688.51M
31.97%878.02M
23.53%832.38M
23.08%807.48M
13.73%614.6M
Other receivables (including interest and dividends)
-37.90%39.01M
-50.28%29.98M
-34.95%48.13M
-22.21%588.6M
-21.75%62.82M
-12.00%60.31M
-11.54%73.99M
8.82%756.63M
-17.08%80.28M
-17.78%68.53M
-Dividend receivable
--555.84K
----
--9.6M
-23.56%526M
----
----
----
11.11%688.15M
----
----
-Accrued interest receivable
----
----
----
----
-18.43%12.67M
2.44%11.84M
14.93%8.59M
18.42%4.02M
0.65%15.53M
1.74%11.56M
-Other receivable
----
----
----
-2.90%62.59M
----
-14.93%48.46M
----
-11.21%64.47M
----
-20.86%56.97M
Advance payment
-57.33%60.21M
-60.82%43.38M
-18.52%92.73M
-25.10%97.13M
152.50%141.12M
240.69%110.72M
136.27%113.81M
200.70%129.68M
33.65%55.89M
27.12%32.5M
Inventories
0.76%889.09M
-0.25%872.35M
18.22%932.33M
21.96%909.74M
41.31%882.34M
47.76%874.57M
25.93%788.66M
21.68%745.94M
6.96%624.41M
7.92%591.88M
Receivable financing
-36.88%147.59M
41.94%396.77M
160.59%449.55M
121.79%464.79M
-41.77%233.82M
-20.07%279.54M
--172.52M
--209.57M
--401.58M
--349.71M
Non-current assets due within one year
----
----
----
----
----
----
--10M
--10M
--10M
--10M
Other current assets
-97.69%18.37M
-98.23%14.17M
-98.23%14.07M
-99.46%4.35M
11.10%795.88M
10.27%801.97M
9.05%795.28M
9.36%798.44M
-5.24%716.34M
-5.66%727.25M
Total current assets
-6.09%5.55B
-3.96%5.75B
6.56%6.23B
0.91%6.68B
-5.45%5.91B
-5.44%5.98B
-11.41%5.85B
-0.04%6.62B
3.33%6.25B
2.31%6.33B
Non Current assets
Other equity investment
-14.25%338.61M
-12.16%338.99M
-4.18%391.93M
-21.31%393.98M
-24.67%394.88M
-27.06%385.9M
-18.81%409.03M
1.19%500.65M
11.90%524.24M
12.92%529.04M
Investment real estate
3.26%25.47M
3.30%25.83M
-8.59%26.19M
-16.15%24.33M
-16.05%24.67M
-13.16%25.01M
0.61%28.65M
1.43%29.02M
1.49%29.38M
-1.71%28.8M
Long-term equity investment
5.33%23.1B
5.39%22.66B
8.74%22.15B
14.69%21.97B
13.74%21.93B
12.54%21.5B
8.96%20.37B
5.39%19.16B
5.97%19.28B
7.33%19.11B
Fixed assets
----
----
----
5.18%2.11B
----
2.93%2.11B
----
-2.80%2B
----
-2.58%2.05B
Constru in process
----
----
----
-7.08%180.72M
----
-1.09%177.36M
----
67.88%194.48M
----
34.83%179.32M
Productive biological assets
-17.10%5.98M
-21.19%6.04M
-21.10%6.53M
-18.48%6.8M
-17.99%7.21M
-15.85%7.66M
-15.41%8.27M
-16.83%8.34M
-16.85%8.79M
-17.60%9.1M
Intangible assets
26.39%464.53M
19.25%435.35M
-7.71%342.67M
-7.63%349.23M
-1.04%367.54M
1.52%365.08M
1.19%371.29M
12.69%378.09M
8.93%371.4M
9.16%359.61M
Development expenditure
-41.90%124.88M
-20.61%155.71M
31.43%234.63M
33.95%229.29M
29.00%214.93M
14.16%196.14M
31.60%178.52M
33.79%171.18M
42.53%166.61M
56.14%171.8M
Long deferred expense
-51.33%7.28M
-48.79%8.25M
-15.86%13.64M
-4.15%14.4M
-4.66%14.95M
-0.67%16.11M
17.87%16.21M
4.57%15.03M
2.71%15.68M
0.83%16.22M
Deferred tax assets
21.40%348M
2.22%309.84M
-14.84%278.15M
3.76%277.06M
25.49%286.66M
84.53%303.12M
210.09%326.62M
92.02%267M
69.66%228.43M
38.60%164.27M
Usufruct assets
-14.78%44.47M
2.53%47.39M
-7.13%46.42M
-11.82%49.11M
-7.17%52.18M
-22.77%46.23M
-5.89%49.98M
6.84%55.69M
4.07%56.22M
12.92%59.86M
Other non current assets
42.73%79.13M
-22.95%49.94M
42.19%159.59M
-25.59%65.59M
-35.45%55.44M
-4.30%64.82M
-7.03%112.24M
-20.10%88.15M
10.06%85.89M
40.23%67.73M
Total non current assets
5.43%27.01B
5.24%26.52B
7.78%25.94B
12.25%25.67B
11.52%25.62B
10.81%25.2B
8.47%24.07B
5.54%22.87B
6.14%22.97B
7.16%22.74B
Total assets
3.27%32.56B
3.48%32.27B
7.54%32.17B
9.70%32.34B
7.89%31.53B
7.27%31.18B
3.91%29.91B
4.24%29.48B
5.53%29.22B
6.06%29.07B
Liabilities
Current liabilities
Short term loan
138.07%1.67B
4.15%678.31M
33.89%778.17M
64.33%803.78M
53.86%700.95M
83.19%651.27M
63.25%581.22M
30.83%489.11M
21.70%455.56M
-4.78%355.52M
Notes payable and accounts payable
-27.78%297.79M
-7.18%418.59M
18.22%411.1M
4.85%416.98M
40.82%412.35M
89.31%450.97M
36.38%347.75M
46.98%397.68M
9.81%292.81M
-9.27%238.22M
-Notes payable
-74.13%3.04M
-58.59%5.86M
-9.43%12.92M
-30.80%10.55M
-19.43%11.76M
-20.51%14.16M
-11.04%14.27M
38.68%15.25M
80.30%14.6M
379.83%17.82M
-Accounts payable
-26.42%294.75M
-5.51%412.72M
19.40%398.17M
6.28%406.43M
43.99%400.58M
98.19%436.81M
39.56%333.47M
47.33%382.43M
7.60%278.21M
-14.85%220.41M
Contract liabilities
43.07%29.92M
-68.08%26.26M
9.95%19.26M
1.84%21M
39.03%20.91M
348.09%82.25M
-29.29%17.52M
-11.52%20.62M
-41.93%15.04M
-7.97%18.36M
Advance receipts
-96.72%959.68K
-96.52%1.01M
-94.02%1.75M
-95.96%1.19M
-19.78%29.29M
-21.06%29.02M
1,836.34%29.18M
1,014.97%29.39M
2,354.39%36.51M
2,041.99%36.76M
Salaries payable
-14.92%65.06M
-31.43%74.49M
-4.99%33.14M
60.95%41.42M
7.25%76.46M
28.54%108.63M
-11.04%34.88M
-39.68%25.73M
7.23%71.3M
-4.40%84.51M
Taxs payable
-7.47%40.58M
20.81%67.08M
2.27%55.16M
-19.51%34.93M
-21.17%43.85M
76.25%55.53M
75.81%53.93M
50.98%43.4M
193.88%55.63M
83.54%31.51M
Other payable (including interest and dividends)
29.97%947.38M
7.09%866.16M
26.11%836.68M
74.20%1.15B
11.15%728.93M
21.96%808.79M
8.82%663.45M
-24.55%658.32M
1.68%655.8M
7.20%663.14M
-Interest payable
-79.94%501.11K
20.74%37.45M
24.55%26.55M
24.61%14.46M
24.62%2.5M
99.93%31.01M
100.03%21.32M
100.00%11.61M
99.99%2M
33.33%15.51M
-Dividend payable
0.00%5.19K
0.00%5.19K
0.00%5.19K
6,518,590.16%338.09M
0.00%5.19K
0.00%5.19K
0.00%5.19K
-100.00%5.19K
0.00%5.19K
0.00%5.19K
-Other payable
30.35%946.87M
6.55%828.71M
26.16%810.12M
22.82%794.26M
11.11%726.43M
20.10%777.77M
7.20%642.12M
1.21%646.71M
1.53%653.79M
6.70%647.63M
Non current liabilities due within one year
-99.22%18.24M
12,691.29%2.33B
13,206.92%2.38B
11,655.86%2.37B
11,102.90%2.35B
-28.24%18.23M
-18.92%17.91M
-10.58%20.13M
-7.72%20.95M
44.19%25.41M
Other current liabilities
15,128.22%403.72M
-69.32%3.27M
5.49%2.39M
-2.07%2.61M
37.79%2.65M
366.16%10.67M
-23.22%2.27M
-5.01%2.67M
-42.72%1.92M
0.90%2.29M
Total current liabilities
-20.40%3.47B
101.67%4.47B
158.63%4.52B
186.60%4.84B
171.72%4.36B
52.18%2.22B
30.27%1.75B
2.89%1.69B
12.68%1.61B
3.86%1.46B
Current liabilities
Bonds payable
----
----
----
----
----
4.15%2.3B
4.39%2.28B
4.60%2.26B
4.81%2.24B
4.89%2.21B
Deferred tax liabilities
65.50%29.13M
15.26%30.03M
104.64%12.82M
-20.23%16.28M
-21.36%17.6M
7.65%26.06M
-88.13%6.27M
46.84%20.41M
112.19%22.38M
144.42%24.21M
Long term deferred income
-13.06%240.7M
-12.15%247.38M
-5.81%273.33M
-10.59%266.65M
-8.10%276.87M
-10.28%281.6M
-4.75%290.19M
-8.05%298.24M
-6.48%301.28M
-2.32%313.86M
Lease liabilities
-8.83%19.15M
22.45%21.49M
9.03%22.34M
-19.05%20.65M
-17.18%21.01M
-24.94%17.55M
-5.68%20.48M
14.52%25.51M
-14.52%25.36M
-33.43%23.38M
Total non current liabilities
-8.40%288.99M
-88.63%298.9M
-88.13%308.49M
-88.34%303.59M
-87.80%315.48M
2.16%2.63B
1.29%2.6B
3.27%2.6B
3.55%2.59B
3.95%2.57B
Total liabilities
-19.60%3.76B
-1.60%4.77B
11.12%4.83B
19.78%5.14B
11.63%4.68B
20.24%4.84B
11.25%4.35B
3.12%4.29B
6.87%4.19B
3.91%4.03B
Shareholders equity
Paid-in capital
6.70%1.24B
0.46%1.17B
0.01%1.16B
0.00%1.16B
0.00%1.16B
0.00%1.16B
0.00%1.16B
0.00%1.16B
0.00%1.16B
0.00%1.16B
Other equity instruments
----
-3.14%542.29M
-0.07%559.65M
-0.04%559.85M
-0.03%559.86M
-0.03%559.87M
-0.00%560.05M
-0.00%560.05M
-0.00%560.05M
-0.00%560.05M
Capital reserve funds
40.12%5.53B
2.24%4.03B
0.13%3.95B
0.16%3.95B
-0.84%3.95B
-0.84%3.95B
-0.74%3.94B
-0.84%3.94B
0.28%3.98B
0.38%3.98B
Surplus reserve funds
5.80%2.49B
5.80%2.49B
8.03%2.35B
8.29%2.35B
8.33%2.35B
8.33%2.35B
10.53%2.18B
10.26%2.17B
10.22%2.17B
10.22%2.17B
Retained profit
3.44%19.53B
5.41%19.38B
9.41%19.33B
10.94%19.12B
10.19%18.88B
7.71%18.39B
2.79%17.67B
4.72%17.23B
6.33%17.13B
8.60%17.07B
Less:Treasury stock
26.31%720.07M
26.31%720.07M
12.72%620.05M
26.85%570.07M
42.51%570.07M
42.51%570.07M
37.50%550.06M
12.34%449.41M
0.00%400.03M
33.33%400.03M
Other composite income
113.93%455.99M
62.35%314.7M
-4.15%306.04M
14.31%342.81M
-14.94%213.15M
-38.08%193.84M
30.81%319.28M
37.29%299.91M
22.22%250.57M
14.12%313.06M
Shareholders equity without minority interests
7.46%28.52B
4.52%27.21B
6.96%27.04B
8.00%26.91B
6.78%26.54B
4.72%26.03B
2.36%25.28B
4.08%24.92B
5.42%24.86B
6.45%24.86B
Minority interests
-10.13%277M
-5.12%288.01M
4.31%299.3M
6.66%294.25M
76.18%308.22M
69.33%303.54M
56.94%286.95M
49.15%275.88M
-8.55%174.95M
1.70%179.26M
Total shareholder equity
7.26%28.8B
4.41%27.5B
6.93%27.34B
7.98%27.21B
7.27%26.85B
5.19%26.34B
2.76%25.57B
4.43%25.19B
5.30%25.03B
6.42%25.04B
Total liabilityies and equity
3.27%32.56B
3.48%32.27B
7.54%32.17B
9.70%32.34B
7.89%31.53B
7.27%31.18B
3.91%29.91B
4.24%29.48B
5.53%29.22B
6.06%29.07B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhongzhu Certified Public Accountants (Special General Partnership)
--
--
--
Zhongzhu Certified Public Accountants (Special General Partnership)
--
--
--
Zhongzhu Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 46.35%1.63B19.59%1.72B23.31%1.86B50.98%1.94B-32.33%1.12B-17.46%1.44B-8.68%1.51B-13.30%1.28B-26.09%1.65B-30.40%1.74B
Transactional financial assets -15.42%1.45B1.11%1.66B16.89%1.76B-5.89%1.74B-10.46%1.71B-25.08%1.64B-41.01%1.51B-16.81%1.85B48.88%1.91B68.35%2.19B
Notes receivable and accounts receivable 35.87%1.32B30.07%1.01B22.24%1.07B12.01%932.33M20.33%971.68M26.36%776.64M-3.14%878.02M-0.09%832.38M-23.89%807.48M-35.38%614.6M
-Notes receivable -99.91%101.15K----------4.55M--111.78M--88.13M----------------
-Accounts receivable 53.51%1.32B46.72%1.01B22.24%1.07B11.46%927.78M6.49%859.9M12.02%688.51M31.97%878.02M23.53%832.38M23.08%807.48M13.73%614.6M
Other receivables (including interest and dividends) -37.90%39.01M-50.28%29.98M-34.95%48.13M-22.21%588.6M-21.75%62.82M-12.00%60.31M-11.54%73.99M8.82%756.63M-17.08%80.28M-17.78%68.53M
-Dividend receivable --555.84K------9.6M-23.56%526M------------11.11%688.15M--------
-Accrued interest receivable -----------------18.43%12.67M2.44%11.84M14.93%8.59M18.42%4.02M0.65%15.53M1.74%11.56M
-Other receivable -------------2.90%62.59M-----14.93%48.46M-----11.21%64.47M-----20.86%56.97M
Advance payment -57.33%60.21M-60.82%43.38M-18.52%92.73M-25.10%97.13M152.50%141.12M240.69%110.72M136.27%113.81M200.70%129.68M33.65%55.89M27.12%32.5M
Inventories 0.76%889.09M-0.25%872.35M18.22%932.33M21.96%909.74M41.31%882.34M47.76%874.57M25.93%788.66M21.68%745.94M6.96%624.41M7.92%591.88M
Receivable financing -36.88%147.59M41.94%396.77M160.59%449.55M121.79%464.79M-41.77%233.82M-20.07%279.54M--172.52M--209.57M--401.58M--349.71M
Non-current assets due within one year --------------------------10M--10M--10M--10M
Other current assets -97.69%18.37M-98.23%14.17M-98.23%14.07M-99.46%4.35M11.10%795.88M10.27%801.97M9.05%795.28M9.36%798.44M-5.24%716.34M-5.66%727.25M
Total current assets -6.09%5.55B-3.96%5.75B6.56%6.23B0.91%6.68B-5.45%5.91B-5.44%5.98B-11.41%5.85B-0.04%6.62B3.33%6.25B2.31%6.33B
Non Current assets
Other equity investment -14.25%338.61M-12.16%338.99M-4.18%391.93M-21.31%393.98M-24.67%394.88M-27.06%385.9M-18.81%409.03M1.19%500.65M11.90%524.24M12.92%529.04M
Investment real estate 3.26%25.47M3.30%25.83M-8.59%26.19M-16.15%24.33M-16.05%24.67M-13.16%25.01M0.61%28.65M1.43%29.02M1.49%29.38M-1.71%28.8M
Long-term equity investment 5.33%23.1B5.39%22.66B8.74%22.15B14.69%21.97B13.74%21.93B12.54%21.5B8.96%20.37B5.39%19.16B5.97%19.28B7.33%19.11B
Fixed assets ------------5.18%2.11B----2.93%2.11B-----2.80%2B-----2.58%2.05B
Constru in process -------------7.08%180.72M-----1.09%177.36M----67.88%194.48M----34.83%179.32M
Productive biological assets -17.10%5.98M-21.19%6.04M-21.10%6.53M-18.48%6.8M-17.99%7.21M-15.85%7.66M-15.41%8.27M-16.83%8.34M-16.85%8.79M-17.60%9.1M
Intangible assets 26.39%464.53M19.25%435.35M-7.71%342.67M-7.63%349.23M-1.04%367.54M1.52%365.08M1.19%371.29M12.69%378.09M8.93%371.4M9.16%359.61M
Development expenditure -41.90%124.88M-20.61%155.71M31.43%234.63M33.95%229.29M29.00%214.93M14.16%196.14M31.60%178.52M33.79%171.18M42.53%166.61M56.14%171.8M
Long deferred expense -51.33%7.28M-48.79%8.25M-15.86%13.64M-4.15%14.4M-4.66%14.95M-0.67%16.11M17.87%16.21M4.57%15.03M2.71%15.68M0.83%16.22M
Deferred tax assets 21.40%348M2.22%309.84M-14.84%278.15M3.76%277.06M25.49%286.66M84.53%303.12M210.09%326.62M92.02%267M69.66%228.43M38.60%164.27M
Usufruct assets -14.78%44.47M2.53%47.39M-7.13%46.42M-11.82%49.11M-7.17%52.18M-22.77%46.23M-5.89%49.98M6.84%55.69M4.07%56.22M12.92%59.86M
Other non current assets 42.73%79.13M-22.95%49.94M42.19%159.59M-25.59%65.59M-35.45%55.44M-4.30%64.82M-7.03%112.24M-20.10%88.15M10.06%85.89M40.23%67.73M
Total non current assets 5.43%27.01B5.24%26.52B7.78%25.94B12.25%25.67B11.52%25.62B10.81%25.2B8.47%24.07B5.54%22.87B6.14%22.97B7.16%22.74B
Total assets 3.27%32.56B3.48%32.27B7.54%32.17B9.70%32.34B7.89%31.53B7.27%31.18B3.91%29.91B4.24%29.48B5.53%29.22B6.06%29.07B
Liabilities
Current liabilities
Short term loan 138.07%1.67B4.15%678.31M33.89%778.17M64.33%803.78M53.86%700.95M83.19%651.27M63.25%581.22M30.83%489.11M21.70%455.56M-4.78%355.52M
Notes payable and accounts payable -27.78%297.79M-7.18%418.59M18.22%411.1M4.85%416.98M40.82%412.35M89.31%450.97M36.38%347.75M46.98%397.68M9.81%292.81M-9.27%238.22M
-Notes payable -74.13%3.04M-58.59%5.86M-9.43%12.92M-30.80%10.55M-19.43%11.76M-20.51%14.16M-11.04%14.27M38.68%15.25M80.30%14.6M379.83%17.82M
-Accounts payable -26.42%294.75M-5.51%412.72M19.40%398.17M6.28%406.43M43.99%400.58M98.19%436.81M39.56%333.47M47.33%382.43M7.60%278.21M-14.85%220.41M
Contract liabilities 43.07%29.92M-68.08%26.26M9.95%19.26M1.84%21M39.03%20.91M348.09%82.25M-29.29%17.52M-11.52%20.62M-41.93%15.04M-7.97%18.36M
Advance receipts -96.72%959.68K-96.52%1.01M-94.02%1.75M-95.96%1.19M-19.78%29.29M-21.06%29.02M1,836.34%29.18M1,014.97%29.39M2,354.39%36.51M2,041.99%36.76M
Salaries payable -14.92%65.06M-31.43%74.49M-4.99%33.14M60.95%41.42M7.25%76.46M28.54%108.63M-11.04%34.88M-39.68%25.73M7.23%71.3M-4.40%84.51M
Taxs payable -7.47%40.58M20.81%67.08M2.27%55.16M-19.51%34.93M-21.17%43.85M76.25%55.53M75.81%53.93M50.98%43.4M193.88%55.63M83.54%31.51M
Other payable (including interest and dividends) 29.97%947.38M7.09%866.16M26.11%836.68M74.20%1.15B11.15%728.93M21.96%808.79M8.82%663.45M-24.55%658.32M1.68%655.8M7.20%663.14M
-Interest payable -79.94%501.11K20.74%37.45M24.55%26.55M24.61%14.46M24.62%2.5M99.93%31.01M100.03%21.32M100.00%11.61M99.99%2M33.33%15.51M
-Dividend payable 0.00%5.19K0.00%5.19K0.00%5.19K6,518,590.16%338.09M0.00%5.19K0.00%5.19K0.00%5.19K-100.00%5.19K0.00%5.19K0.00%5.19K
-Other payable 30.35%946.87M6.55%828.71M26.16%810.12M22.82%794.26M11.11%726.43M20.10%777.77M7.20%642.12M1.21%646.71M1.53%653.79M6.70%647.63M
Non current liabilities due within one year -99.22%18.24M12,691.29%2.33B13,206.92%2.38B11,655.86%2.37B11,102.90%2.35B-28.24%18.23M-18.92%17.91M-10.58%20.13M-7.72%20.95M44.19%25.41M
Other current liabilities 15,128.22%403.72M-69.32%3.27M5.49%2.39M-2.07%2.61M37.79%2.65M366.16%10.67M-23.22%2.27M-5.01%2.67M-42.72%1.92M0.90%2.29M
Total current liabilities -20.40%3.47B101.67%4.47B158.63%4.52B186.60%4.84B171.72%4.36B52.18%2.22B30.27%1.75B2.89%1.69B12.68%1.61B3.86%1.46B
Current liabilities
Bonds payable --------------------4.15%2.3B4.39%2.28B4.60%2.26B4.81%2.24B4.89%2.21B
Deferred tax liabilities 65.50%29.13M15.26%30.03M104.64%12.82M-20.23%16.28M-21.36%17.6M7.65%26.06M-88.13%6.27M46.84%20.41M112.19%22.38M144.42%24.21M
Long term deferred income -13.06%240.7M-12.15%247.38M-5.81%273.33M-10.59%266.65M-8.10%276.87M-10.28%281.6M-4.75%290.19M-8.05%298.24M-6.48%301.28M-2.32%313.86M
Lease liabilities -8.83%19.15M22.45%21.49M9.03%22.34M-19.05%20.65M-17.18%21.01M-24.94%17.55M-5.68%20.48M14.52%25.51M-14.52%25.36M-33.43%23.38M
Total non current liabilities -8.40%288.99M-88.63%298.9M-88.13%308.49M-88.34%303.59M-87.80%315.48M2.16%2.63B1.29%2.6B3.27%2.6B3.55%2.59B3.95%2.57B
Total liabilities -19.60%3.76B-1.60%4.77B11.12%4.83B19.78%5.14B11.63%4.68B20.24%4.84B11.25%4.35B3.12%4.29B6.87%4.19B3.91%4.03B
Shareholders equity
Paid-in capital 6.70%1.24B0.46%1.17B0.01%1.16B0.00%1.16B0.00%1.16B0.00%1.16B0.00%1.16B0.00%1.16B0.00%1.16B0.00%1.16B
Other equity instruments -----3.14%542.29M-0.07%559.65M-0.04%559.85M-0.03%559.86M-0.03%559.87M-0.00%560.05M-0.00%560.05M-0.00%560.05M-0.00%560.05M
Capital reserve funds 40.12%5.53B2.24%4.03B0.13%3.95B0.16%3.95B-0.84%3.95B-0.84%3.95B-0.74%3.94B-0.84%3.94B0.28%3.98B0.38%3.98B
Surplus reserve funds 5.80%2.49B5.80%2.49B8.03%2.35B8.29%2.35B8.33%2.35B8.33%2.35B10.53%2.18B10.26%2.17B10.22%2.17B10.22%2.17B
Retained profit 3.44%19.53B5.41%19.38B9.41%19.33B10.94%19.12B10.19%18.88B7.71%18.39B2.79%17.67B4.72%17.23B6.33%17.13B8.60%17.07B
Less:Treasury stock 26.31%720.07M26.31%720.07M12.72%620.05M26.85%570.07M42.51%570.07M42.51%570.07M37.50%550.06M12.34%449.41M0.00%400.03M33.33%400.03M
Other composite income 113.93%455.99M62.35%314.7M-4.15%306.04M14.31%342.81M-14.94%213.15M-38.08%193.84M30.81%319.28M37.29%299.91M22.22%250.57M14.12%313.06M
Shareholders equity without minority interests 7.46%28.52B4.52%27.21B6.96%27.04B8.00%26.91B6.78%26.54B4.72%26.03B2.36%25.28B4.08%24.92B5.42%24.86B6.45%24.86B
Minority interests -10.13%277M-5.12%288.01M4.31%299.3M6.66%294.25M76.18%308.22M69.33%303.54M56.94%286.95M49.15%275.88M-8.55%174.95M1.70%179.26M
Total shareholder equity 7.26%28.8B4.41%27.5B6.93%27.34B7.98%27.21B7.27%26.85B5.19%26.34B2.76%25.57B4.43%25.19B5.30%25.03B6.42%25.04B
Total liabilityies and equity 3.27%32.56B3.48%32.27B7.54%32.17B9.70%32.34B7.89%31.53B7.27%31.18B3.91%29.91B4.24%29.48B5.53%29.22B6.06%29.07B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Zhongzhu Certified Public Accountants (Special General Partnership)------Zhongzhu Certified Public Accountants (Special General Partnership)------Zhongzhu Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg